Cytokinetics Prices Upsized Public Offering Of Common Stock At $71 Per Share RTT News 10:02 Thu, 07 May
Assessing Cytokinetics (CYTK) Valuation After Recent Share Price Momentum Simply Wall St 11:07 Wed, 06 May
Cytokinetics’ Phase III Data Position Myqorzo To Treat Full HCM Patient Spectrum Scrip Pharma Intelligence 22:47 Tue, 05 May
Cytokinetics Stock Rallies After Pivotal Heart Disease Study Hits Dual Primary Endpoints Benzinga 15:56 Tue, 05 May Article paywall
Cytokinetics Shares Jump As Phase 3 acacia-HCM Trial Of Aficamten Meets Dual Primary Endpoints RTT News 13:34 Tue, 05 May
STAT Plus: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease STAT 12:36 Tue, 05 May
Cytokinetics To Report Topline acacia-HCM Phase 3 Results For Aficamten Today RTT News 05:24 Tue, 05 May
